Evidence map›Paper›PMID 35589871›Full record

ArticleScientific reports2022

The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway.

Anne K Örtqvist, Maria C Magnus, Jonas Söderling, Laura Oakley, Anne-Marie Nybo Andersen, Siri E Håberg, Olof Stephansson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark.Acta obstetricia et gynecologica Scandinavica · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Anne K ÖrtqvistClinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Solna, T2:02, 171 76, Stockholm, Sweden. Anne.ortqvist@ki.se.
Maria C MagnusCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Jonas SöderlingClinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Solna, T2:02, 171 76, Stockholm, Sweden.
Laura OakleyCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Anne-Marie Nybo AndersenDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Siri E HåbergCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Olof StephanssonClinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Solna, T2:02, 171 76, Stockholm, Sweden.
Karolinska Institutet · SENorwegian Institute of Public Health · NOLondon School of Hygiene & Tropical Medicine · GBUniversity of Copenhagen · DKVisby lasarett · SE

Funding

Wellcome Trust 105545
6 · The paper itself

Abstract

The objectives of the current study were to identify risk factors for SARS-CoV-2 positivity, and to address how different testing strategies, choice of comparison group, and population background characteristics may influence observed associations. National registries data for 107,627 pregnant women in Sweden and 81,195 in Norway, were used to identify risk factors for SARS-CoV-2, separately for women under non-universal testing (testing by indication) and universal testing (testing of all pregnant women in contact with a delivery ward). We also investigated underlying characteristics associated with testing for SARS-CoV-2. Overall, 2.1% of pregnant women in Sweden and 1.1% in Norway were test-positive during the pandemic's first 18 months. We show that the choice of test strategy for SARS-CoV-2 provided different associations with risk factors for the disease; for instance, women who were overweight, obese or had gestational diabetes had increased odds of being test-positive under non-universal testing, but not under universal testing. Nevertheless, a consistent pattern of association between being born in the Middle East and Africa and test-positivity was found independent of test strategy and in both countries. These women were also less likely to get tested. Our results are useful to consider for surveillance and clinical recommendations for pregnant women during the current and future pandemics.

Indexed as

COVID-19Pregnancy Complications, InfectiousFemaleHumansPregnancyRegistriesSARS-CoV-2Sweden

Identifiers

PMID35589871
PMCPMC9120467
OpenAlexW4280598532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.